Although PDK1 transgenic mice did not exhibit changes in mammary gland development, function and tumorigenicity, they were markedly sensitive to GW501516 treatment, where median tumor-free survival was reduced four-fold in comparison to a two-fold reduction in GW501516-treated wild-type mice. Here, PDK1 is linked to neoplasm.